1 of 2
Amid the COVID-19 crisis and the looming economic recession, the Diabetes Diagnostics market worldwide will grow by a projected US$12.8 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 5.8%. Test Strips, one of the segments analyzed and sized in this study, is forecast to grow at over 7% and reach a market size of US$11.3 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Test Strips market will be reset to a new normal which going forward in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.
As part of the new emerging geographic scenario, the United States is forecast to readjust to a 4.6% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$387.9 Million to the region's size over the next 7 to 8 years. In addition, over US$371.8 Million worth of projected demand in the region will come from Rest of the European markets. In Japan, the Test Strips segment will reach a market size of US$383.9 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Diabetes Diagnostics market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world’s second largest economy will grow at 9.8% over the next couple of years and add approximately US$3.5 Billion in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Diabetes Diagnostics market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include, among others:
A.Menarini Diagnostics Ltd, Abbott Diabetes Care Inc, Acon Laboratories Inc, AgaMatrix Inc, Apex Biotechnology Corporation, ARKRAY Inc, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Beckman Coulter Inc, Becton, Dickinson and Company, BIONIME Corporation, Bio-Rad Laboratories Inc, Danaher Corporation, DexCom Inc, Diazyme Laboratories Inc, EKF Diagnostics Holdings Plc, HemoCue® AB, LifeScan, Inc, Medtronic PLC, Nova Biomedical Corporation, OSANG Healthcare Co. Ltd, PTS Diagnostics, Sanofi S.A, Sanwa Kagaku Kenkyusho Co Ltd, Siemens Healthineers, Sinocare Inc, TaiDoc Technology Corporation, Tandem Diabetes Care Inc, Terumo Corporation, Tosoh Bioscience Inc, Trinity Biotech plc, Trividia Health Inc, Ypsomed AG
As part of the new emerging geographic scenario, the United States is forecast to readjust to a 4.6% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$387.9 Million to the region's size over the next 7 to 8 years. In addition, over US$371.8 Million worth of projected demand in the region will come from Rest of the European markets. In Japan, the Test Strips segment will reach a market size of US$383.9 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Diabetes Diagnostics market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world’s second largest economy will grow at 9.8% over the next couple of years and add approximately US$3.5 Billion in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Diabetes Diagnostics market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include, among others:
A.Menarini Diagnostics Ltd, Abbott Diabetes Care Inc, Acon Laboratories Inc, AgaMatrix Inc, Apex Biotechnology Corporation, ARKRAY Inc, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Beckman Coulter Inc, Becton, Dickinson and Company, BIONIME Corporation, Bio-Rad Laboratories Inc, Danaher Corporation, DexCom Inc, Diazyme Laboratories Inc, EKF Diagnostics Holdings Plc, HemoCue® AB, LifeScan, Inc, Medtronic PLC, Nova Biomedical Corporation, OSANG Healthcare Co. Ltd, PTS Diagnostics, Sanofi S.A, Sanwa Kagaku Kenkyusho Co Ltd, Siemens Healthineers, Sinocare Inc, TaiDoc Technology Corporation, Tandem Diabetes Care Inc, Terumo Corporation, Tosoh Bioscience Inc, Trinity Biotech plc, Trividia Health Inc, Ypsomed AG
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Diabetes Diagnostics: Towards Easier, Economic, and Efficient Management of the Global Diabetes Epidemic
Evolution of Diabetes Testing over the Years with Key Features in Each Period
Growth Drivers in a Nutshell
Recent Market Activity
Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices
Diabetes Emerges as One of the Leading Causes of Death
Etiological Factors Causing Diabetes
Future Prospects Remain Favorable for Diabetes Diagnostics Market
Developed Regions Remain Primary Revenue Contributors
Developing Countries Continue to Offer Significant Growth Opportunities
Key Factors Driving Sales of Diabetes Diagnostics in Developing Regions
Global Competitor Market Shares
Diabetes Diagnostics Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
Stable Economic Scenario to Underpin Market Expansion
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
A.Menarini Diagnostics Ltd. (UK)
Abbott Diabetes Care, Inc. (USA)
Acon Laboratories, Inc. (USA)
AgaMatrix, Inc. (USA)
Apex Biotechnology Corporation (Taiwan)
ARKRAY, Inc. (Japan)
Ascensia Diabetes Care Holdings AG (Switzerland)
B. Braun Melsungen AG (Germany)
Becton, Dickinson and Company (USA)
BIONIME Corporation (Taiwan)
Bio-Rad Laboratories, Inc. (USA)
Danaher Corporation (USA)
Beckman Coulter, Inc. (USA)
HemoCue® AB (Sweden)
DexCom, Inc. (USA)
Diazyme Laboratories Inc. (USA)
EKF Diagnostics Holdings Plc (UK)
LifeScan, Inc. (USA)
Medtronic PLC (Ireland)
Nova Biomedical Corporation (USA)
OSANG Healthcare Co., Ltd. (South Korea)
Roche Diabetes Care, Inc. (USA)
Sanofi S.A. (France)
Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
Siemens Healthineers (Germany)
Sinocare, Inc. (China)
PTS Diagnostics (USA)
Trividia Health, Inc. (USA)
TaiDoc Technology Corporation (Taiwan)
Tandem Diabetes Care, Inc. (USA)
Terumo Corporation (Japan)
Tosoh Bioscience, Inc. (USA)
Trinity Biotech plc (Ireland)
Ypsomed AG (Switzerland)
3. MARKET TRENDS & DRIVERS
Growing Prominence of Real-Time Glucose Sensing and Monitoring Drive Robust Demand for Minimally-Invasive CGM Devices
CGM Market Gradually Breaks through Barriers to Adoption
Intensive Care Units: A Highly Promising Market for CGMs
Proven Efficacy for Development of Intervention Strategies Drives Demand for HbA1c Testing Devices
Rising Popularity of Near Patient Testing Benefits Prospects for HbA1c Devices
Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
Home HbA1c Testing: An Overview
Glycated Albumin: A Potential Threat to HbA1c?
Approval for HbA1c Testing for Diabetes Diagnosis: An Opportunity to Tap
Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?
HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants
ESC and ADA Release Revised Guidelines for HbA1c Testing
Undiagnosed Diabetes: A Major Healthcare Challenge Offering Huge Untapped Potential
Undiagnosed Diabetics: More Prone to Cardiovascular Diseases
Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices
Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Lead to Cardiovascular Complications
High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market
Rising Expenditure on Diabetes Care Drives Diagnostic Devices Sales
Increasing Obesity Levels Underpins Market Growth
Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Dominate Sales
Cost: The Ultimate Factor Favoring Growth in Demand for Blood Glucose Monitoring Systems
Self-Monitoring/Household Blood Glucose: Sustaining Growth in Demand
Key Trends in the Glucose Meter/Monitoring Systems
Smartphone Penetration Favors SMBG Market
Demand for BGM Products to Witness Varying Patterns in Developed and Developing Markets
Barriers to Adoption of New Technology in BGM Products
Accuracy Issues Plague Blood Glucose Meters Market
Advancements in Glucose Monitoring Devices Offers a New Ray of Hope
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Diabetes Diagnostics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 2: Diabetes Diagnostics Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
TABLE 3: Diabetes Diagnostics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
TABLE 4: Test Strips (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 5: Test Strips (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 6: Test Strips (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 7: Lancets (Product Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
TABLE 8: Lancets (Product Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
TABLE 9: Lancets (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
TABLE 10: Analog Glucose Monitor (Product Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
TABLE 11: Analog Glucose Monitor (Product Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
TABLE 12: Analog Glucose Monitor (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 13: Continuous Glucose Monitor (Product Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
TABLE 14: Continuous Glucose Monitor (Product Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
TABLE 15: Continuous Glucose Monitor (Product Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
TABLE 16: Syringes (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 17: Syringes (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 18: Syringes (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 19: Pens (Product Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
TABLE 20: Pens (Product Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019
TABLE 21: Pens (Product Type) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
TABLE 22: Pumps (Product Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
TABLE 23: Pumps (Product Type) Global Historic Demand in US$ Million by Region/Country: 2012 to 2019
TABLE 24: Pumps (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 25: Injectors (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 26: Injectors (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 27: Injectors (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Diabetes Diagnostics Market Share (in %) by Company: 2020 & 2025
Market Analytics
TABLE 28: United States Diabetes Diagnostics Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
TABLE 29: Diabetes Diagnostics Market in the United States by Product Type: A Historic Review in US$ Million for 2012-2019
TABLE 30: United States Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
CANADA
TABLE 31: Canadian Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
TABLE 32: Canadian Diabetes Diagnostics Historic Market Review by Product Type in US$ Million: 2012-2019
TABLE 33: Diabetes Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
JAPAN
TABLE 34: Japanese Market for Diabetes Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
TABLE 35: Diabetes Diagnostics Market in Japan: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
TABLE 36: Japanese Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
CHINA
TABLE 37: Chinese Diabetes Diagnostics Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
TABLE 38: Diabetes Diagnostics Historic Market Analysis in China in US$ Million by Product Type: 2012-2019
TABLE 39: Chinese Diabetes Diagnostics Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
EUROPE
Market Facts & Figures
European Diabetes Diagnostics Market: Competitor Market Share Scenario (in %) for 2020 & 2025
Market Analytics
TABLE 40: European Diabetes Diagnostics Market Demand Scenario in US$ Million by Region/Country: 2020-2027
TABLE 41: Diabetes Diagnostics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
TABLE 42: European Diabetes Diagnostics Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
TABLE 43: European Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
TABLE 44: Diabetes Diagnostics Market in Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019
TABLE 45: European Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
FRANCE
TABLE 46: Diabetes Diagnostics Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 47: French Diabetes Diagnostics Historic Market Scenario in US$ Million by Product Type: 2012-2019
TABLE 48: French Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
GERMANY
TABLE 49: Diabetes Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
TABLE 50: German Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
TABLE 51: German Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
ITALY
TABLE 52: Italian Diabetes Diagnostics Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
TABLE 53: Diabetes Diagnostics Historic Market Analysis in Italy in US$ Million by Product Type: 2012-2019
TABLE 54: Italian Diabetes Diagnostics Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED KINGDOM
TABLE 55: United Kingdom Market for Diabetes Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
TABLE 56: Diabetes Diagnostics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
TABLE 57: United Kingdom Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
SPAIN
TABLE 58: Spanish Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
TABLE 59: Spanish Diabetes Diagnostics Historic Market Review by Product Type in US$ Million: 2012-2019
TABLE 60: Diabetes Diagnostics Market in Spain: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
RUSSIA
TABLE 61: Russian Diabetes Diagnostics Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
TABLE 62: Diabetes Diagnostics Market in Russia by Product Type: A Historic Review in US$ Million for 2012-2019
TABLE 63: Russian Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
REST OF EUROPE
TABLE 64: Rest of Europe Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
TABLE 65: Diabetes Diagnostics Market in Rest of Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019
TABLE 66: Rest of Europe Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
ASIA-PACIFIC
TABLE 67: Asia-Pacific Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 68: Diabetes Diagnostics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
TABLE 69: Asia-Pacific Diabetes Diagnostics Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
TABLE 70: Diabetes Diagnostics Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 71: Asia-Pacific Diabetes Diagnostics Historic Market Scenario in US$ Million by Product Type: 2012-2019
TABLE 72: Asia-Pacific Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
AUSTRALIA
TABLE 73: Diabetes Diagnostics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
TABLE 74: Australian Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
TABLE 75: Australian Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
INDIA
TABLE 76: Indian Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
TABLE 77: Indian Diabetes Diagnostics Historic Market Review by Product Type in US$ Million: 2012-2019
TABLE 78: Diabetes Diagnostics Market in India: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
SOUTH KOREA
TABLE 79: Diabetes Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
TABLE 80: South Korean Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
TABLE 81: Diabetes Diagnostics Market Share Distribution in South Korea by Product Type: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
TABLE 82: Rest of Asia-Pacific Market for Diabetes Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
TABLE 83: Diabetes Diagnostics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
TABLE 84: Rest of Asia-Pacific Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
LATIN AMERICA
TABLE 85: Latin American Diabetes Diagnostics Market Trends by Region/Country in US$ Million: 2020-2027
TABLE 86: Diabetes Diagnostics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
TABLE 87: Latin American Diabetes Diagnostics Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
TABLE 88: Latin American Diabetes Diagnostics Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
TABLE 89: Diabetes Diagnostics Historic Market Analysis in Latin America in US$ Million by Product Type: 2012-2019
TABLE 90: Latin American Diabetes Diagnostics Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
ARGENTINA
TABLE 91: Argentinean Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
TABLE 92: Diabetes Diagnostics Market in Argentina in US$ Million by Product Type: A Historic Review for the Period 2012-2019
TABLE 93: Argentinean Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
BRAZIL
TABLE 94: Diabetes Diagnostics Market in Brazil by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 95: Brazilian Diabetes Diagnostics Historic Market Scenario in US$ Million by Product Type: 2012-2019
TABLE 96: Brazilian Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
MEXICO
TABLE 97: Diabetes Diagnostics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
TABLE 98: Mexican Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
TABLE 99: Mexican Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
TABLE 100: Rest of Latin America Diabetes Diagnostics Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
TABLE 101: Diabetes Diagnostics Market in Rest of Latin America by Product Type: A Historic Review in US$ Million for 2012-2019
TABLE 102: Rest of Latin America Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
MIDDLE EAST
TABLE 103: The Middle East Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 104: Diabetes Diagnostics Market in the Middle East by Region/Country in US$ Million: 2012-2019
TABLE 105: The Middle East Diabetes Diagnostics Market Share Breakdown by Region/Country: 2012, 2020, and 2027
TABLE 106: The Middle East Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
TABLE 107: The Middle East Diabetes Diagnostics Historic Market by Product Type in US$ Million: 2012-2019
TABLE 108: Diabetes Diagnostics Market in the Middle East: Percentage Share Breakdown of Sales by Product Type for 2012,2020, and 2027
IRAN
TABLE 109: Iranian Market for Diabetes Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
TABLE 110: Diabetes Diagnostics Market in Iran: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
TABLE 111: Iranian Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
ISRAEL
TABLE 112: Israeli Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
TABLE 113: Diabetes Diagnostics Market in Israel in US$ Million by Product Type: A Historic Review for the Period 2012-2019
TABLE 114: Israeli Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
SAUDI ARABIA
TABLE 115: Saudi Arabian Diabetes Diagnostics Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
TABLE 116: Diabetes Diagnostics Historic Market Analysis in Saudi Arabia in US$ Million by Product Type: 2012-2019
TABLE 117: Saudi Arabian Diabetes Diagnostics Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED ARAB EMIRATES
TABLE 118: Diabetes Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
TABLE 119: United Arab Emirates Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
TABLE 120: Diabetes Diagnostics Market Share Distribution in United Arab Emirates by Product Type: 2012 VS 2020 VS 2027
REST OF MIDDLE EAST
TABLE 121: Diabetes Diagnostics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
TABLE 122: Rest of Middle East Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
TABLE 123: Rest of Middle East Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
AFRICA
TABLE 124: African Diabetes Diagnostics Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
TABLE 125: Diabetes Diagnostics Market in Africa by Product Type: A Historic Review in US$ Million for 2012-2019
TABLE 126: African Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 59
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Diabetes Diagnostics: Towards Easier, Economic, and Efficient Management of the Global Diabetes Epidemic
Evolution of Diabetes Testing over the Years with Key Features in Each Period
Growth Drivers in a Nutshell
Recent Market Activity
Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices
Diabetes Emerges as One of the Leading Causes of Death
Etiological Factors Causing Diabetes
Future Prospects Remain Favorable for Diabetes Diagnostics Market
Developed Regions Remain Primary Revenue Contributors
Developing Countries Continue to Offer Significant Growth Opportunities
Key Factors Driving Sales of Diabetes Diagnostics in Developing Regions
Global Competitor Market Shares
Diabetes Diagnostics Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
Stable Economic Scenario to Underpin Market Expansion
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
A.Menarini Diagnostics Ltd. (UK)
Abbott Diabetes Care, Inc. (USA)
Acon Laboratories, Inc. (USA)
AgaMatrix, Inc. (USA)
Apex Biotechnology Corporation (Taiwan)
ARKRAY, Inc. (Japan)
Ascensia Diabetes Care Holdings AG (Switzerland)
B. Braun Melsungen AG (Germany)
Becton, Dickinson and Company (USA)
BIONIME Corporation (Taiwan)
Bio-Rad Laboratories, Inc. (USA)
Danaher Corporation (USA)
Beckman Coulter, Inc. (USA)
HemoCue® AB (Sweden)
DexCom, Inc. (USA)
Diazyme Laboratories Inc. (USA)
EKF Diagnostics Holdings Plc (UK)
LifeScan, Inc. (USA)
Medtronic PLC (Ireland)
Nova Biomedical Corporation (USA)
OSANG Healthcare Co., Ltd. (South Korea)
Roche Diabetes Care, Inc. (USA)
Sanofi S.A. (France)
Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
Siemens Healthineers (Germany)
Sinocare, Inc. (China)
PTS Diagnostics (USA)
Trividia Health, Inc. (USA)
TaiDoc Technology Corporation (Taiwan)
Tandem Diabetes Care, Inc. (USA)
Terumo Corporation (Japan)
Tosoh Bioscience, Inc. (USA)
Trinity Biotech plc (Ireland)
Ypsomed AG (Switzerland)
3. MARKET TRENDS & DRIVERS
Growing Prominence of Real-Time Glucose Sensing and Monitoring Drive Robust Demand for Minimally-Invasive CGM Devices
CGM Market Gradually Breaks through Barriers to Adoption
Intensive Care Units: A Highly Promising Market for CGMs
Proven Efficacy for Development of Intervention Strategies Drives Demand for HbA1c Testing Devices
Rising Popularity of Near Patient Testing Benefits Prospects for HbA1c Devices
Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
Home HbA1c Testing: An Overview
Glycated Albumin: A Potential Threat to HbA1c?
Approval for HbA1c Testing for Diabetes Diagnosis: An Opportunity to Tap
Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?
HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants
ESC and ADA Release Revised Guidelines for HbA1c Testing
Undiagnosed Diabetes: A Major Healthcare Challenge Offering Huge Untapped Potential
Undiagnosed Diabetics: More Prone to Cardiovascular Diseases
Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices
Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Lead to Cardiovascular Complications
High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market
Rising Expenditure on Diabetes Care Drives Diagnostic Devices Sales
Increasing Obesity Levels Underpins Market Growth
Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Dominate Sales
Cost: The Ultimate Factor Favoring Growth in Demand for Blood Glucose Monitoring Systems
Self-Monitoring/Household Blood Glucose: Sustaining Growth in Demand
Key Trends in the Glucose Meter/Monitoring Systems
Smartphone Penetration Favors SMBG Market
Demand for BGM Products to Witness Varying Patterns in Developed and Developing Markets
Barriers to Adoption of New Technology in BGM Products
Accuracy Issues Plague Blood Glucose Meters Market
Advancements in Glucose Monitoring Devices Offers a New Ray of Hope
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Diabetes Diagnostics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 2: Diabetes Diagnostics Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
TABLE 3: Diabetes Diagnostics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
TABLE 4: Test Strips (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 5: Test Strips (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 6: Test Strips (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 7: Lancets (Product Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
TABLE 8: Lancets (Product Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
TABLE 9: Lancets (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
TABLE 10: Analog Glucose Monitor (Product Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
TABLE 11: Analog Glucose Monitor (Product Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
TABLE 12: Analog Glucose Monitor (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 13: Continuous Glucose Monitor (Product Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
TABLE 14: Continuous Glucose Monitor (Product Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
TABLE 15: Continuous Glucose Monitor (Product Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
TABLE 16: Syringes (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 17: Syringes (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 18: Syringes (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 19: Pens (Product Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
TABLE 20: Pens (Product Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019
TABLE 21: Pens (Product Type) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
TABLE 22: Pumps (Product Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
TABLE 23: Pumps (Product Type) Global Historic Demand in US$ Million by Region/Country: 2012 to 2019
TABLE 24: Pumps (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 25: Injectors (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 26: Injectors (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 27: Injectors (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Diabetes Diagnostics Market Share (in %) by Company: 2020 & 2025
Market Analytics
TABLE 28: United States Diabetes Diagnostics Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
TABLE 29: Diabetes Diagnostics Market in the United States by Product Type: A Historic Review in US$ Million for 2012-2019
TABLE 30: United States Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
CANADA
TABLE 31: Canadian Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
TABLE 32: Canadian Diabetes Diagnostics Historic Market Review by Product Type in US$ Million: 2012-2019
TABLE 33: Diabetes Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
JAPAN
TABLE 34: Japanese Market for Diabetes Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
TABLE 35: Diabetes Diagnostics Market in Japan: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
TABLE 36: Japanese Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
CHINA
TABLE 37: Chinese Diabetes Diagnostics Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
TABLE 38: Diabetes Diagnostics Historic Market Analysis in China in US$ Million by Product Type: 2012-2019
TABLE 39: Chinese Diabetes Diagnostics Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
EUROPE
Market Facts & Figures
European Diabetes Diagnostics Market: Competitor Market Share Scenario (in %) for 2020 & 2025
Market Analytics
TABLE 40: European Diabetes Diagnostics Market Demand Scenario in US$ Million by Region/Country: 2020-2027
TABLE 41: Diabetes Diagnostics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
TABLE 42: European Diabetes Diagnostics Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
TABLE 43: European Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
TABLE 44: Diabetes Diagnostics Market in Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019
TABLE 45: European Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
FRANCE
TABLE 46: Diabetes Diagnostics Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 47: French Diabetes Diagnostics Historic Market Scenario in US$ Million by Product Type: 2012-2019
TABLE 48: French Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
GERMANY
TABLE 49: Diabetes Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
TABLE 50: German Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
TABLE 51: German Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
ITALY
TABLE 52: Italian Diabetes Diagnostics Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
TABLE 53: Diabetes Diagnostics Historic Market Analysis in Italy in US$ Million by Product Type: 2012-2019
TABLE 54: Italian Diabetes Diagnostics Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED KINGDOM
TABLE 55: United Kingdom Market for Diabetes Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
TABLE 56: Diabetes Diagnostics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
TABLE 57: United Kingdom Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
SPAIN
TABLE 58: Spanish Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
TABLE 59: Spanish Diabetes Diagnostics Historic Market Review by Product Type in US$ Million: 2012-2019
TABLE 60: Diabetes Diagnostics Market in Spain: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
RUSSIA
TABLE 61: Russian Diabetes Diagnostics Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
TABLE 62: Diabetes Diagnostics Market in Russia by Product Type: A Historic Review in US$ Million for 2012-2019
TABLE 63: Russian Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
REST OF EUROPE
TABLE 64: Rest of Europe Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
TABLE 65: Diabetes Diagnostics Market in Rest of Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019
TABLE 66: Rest of Europe Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
ASIA-PACIFIC
TABLE 67: Asia-Pacific Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 68: Diabetes Diagnostics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
TABLE 69: Asia-Pacific Diabetes Diagnostics Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
TABLE 70: Diabetes Diagnostics Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 71: Asia-Pacific Diabetes Diagnostics Historic Market Scenario in US$ Million by Product Type: 2012-2019
TABLE 72: Asia-Pacific Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
AUSTRALIA
TABLE 73: Diabetes Diagnostics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
TABLE 74: Australian Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
TABLE 75: Australian Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
INDIA
TABLE 76: Indian Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
TABLE 77: Indian Diabetes Diagnostics Historic Market Review by Product Type in US$ Million: 2012-2019
TABLE 78: Diabetes Diagnostics Market in India: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
SOUTH KOREA
TABLE 79: Diabetes Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
TABLE 80: South Korean Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
TABLE 81: Diabetes Diagnostics Market Share Distribution in South Korea by Product Type: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
TABLE 82: Rest of Asia-Pacific Market for Diabetes Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
TABLE 83: Diabetes Diagnostics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
TABLE 84: Rest of Asia-Pacific Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
LATIN AMERICA
TABLE 85: Latin American Diabetes Diagnostics Market Trends by Region/Country in US$ Million: 2020-2027
TABLE 86: Diabetes Diagnostics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
TABLE 87: Latin American Diabetes Diagnostics Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
TABLE 88: Latin American Diabetes Diagnostics Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
TABLE 89: Diabetes Diagnostics Historic Market Analysis in Latin America in US$ Million by Product Type: 2012-2019
TABLE 90: Latin American Diabetes Diagnostics Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
ARGENTINA
TABLE 91: Argentinean Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
TABLE 92: Diabetes Diagnostics Market in Argentina in US$ Million by Product Type: A Historic Review for the Period 2012-2019
TABLE 93: Argentinean Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
BRAZIL
TABLE 94: Diabetes Diagnostics Market in Brazil by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 95: Brazilian Diabetes Diagnostics Historic Market Scenario in US$ Million by Product Type: 2012-2019
TABLE 96: Brazilian Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
MEXICO
TABLE 97: Diabetes Diagnostics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
TABLE 98: Mexican Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
TABLE 99: Mexican Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
TABLE 100: Rest of Latin America Diabetes Diagnostics Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
TABLE 101: Diabetes Diagnostics Market in Rest of Latin America by Product Type: A Historic Review in US$ Million for 2012-2019
TABLE 102: Rest of Latin America Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
MIDDLE EAST
TABLE 103: The Middle East Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 104: Diabetes Diagnostics Market in the Middle East by Region/Country in US$ Million: 2012-2019
TABLE 105: The Middle East Diabetes Diagnostics Market Share Breakdown by Region/Country: 2012, 2020, and 2027
TABLE 106: The Middle East Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
TABLE 107: The Middle East Diabetes Diagnostics Historic Market by Product Type in US$ Million: 2012-2019
TABLE 108: Diabetes Diagnostics Market in the Middle East: Percentage Share Breakdown of Sales by Product Type for 2012,2020, and 2027
IRAN
TABLE 109: Iranian Market for Diabetes Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
TABLE 110: Diabetes Diagnostics Market in Iran: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
TABLE 111: Iranian Diabetes Diagnostics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
ISRAEL
TABLE 112: Israeli Diabetes Diagnostics Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
TABLE 113: Diabetes Diagnostics Market in Israel in US$ Million by Product Type: A Historic Review for the Period 2012-2019
TABLE 114: Israeli Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
SAUDI ARABIA
TABLE 115: Saudi Arabian Diabetes Diagnostics Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
TABLE 116: Diabetes Diagnostics Historic Market Analysis in Saudi Arabia in US$ Million by Product Type: 2012-2019
TABLE 117: Saudi Arabian Diabetes Diagnostics Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED ARAB EMIRATES
TABLE 118: Diabetes Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
TABLE 119: United Arab Emirates Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
TABLE 120: Diabetes Diagnostics Market Share Distribution in United Arab Emirates by Product Type: 2012 VS 2020 VS 2027
REST OF MIDDLE EAST
TABLE 121: Diabetes Diagnostics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
TABLE 122: Rest of Middle East Diabetes Diagnostics Historic Market Analysis in US$ Million by Product Type: 2012-2019
TABLE 123: Rest of Middle East Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
AFRICA
TABLE 124: African Diabetes Diagnostics Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
TABLE 125: Diabetes Diagnostics Market in Africa by Product Type: A Historic Review in US$ Million for 2012-2019
TABLE 126: African Diabetes Diagnostics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 59
Note: Product cover images may vary from those shown
3 of 2
LOADING...
